This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Align Technology, based in California, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The clear aligner system corrects malocclusion using nearly invisible and removable appliances that gently move the tooth to a desired final position.
PAREXEL Announces Acquisition by Pamplona Capital for $5B
by Zacks Equity Research
PAREXEL International Corporation (PRXL) recently announced that it has agreed to be acquired by Pamplona Capital Management, LLP.
Why Investors Should Retain Molina Healthcare (MOH) Stock
by Zacks Equity Research
Molina Healthcare, Inc. (MOH) consistent operating performance is backed by its steady increase in premiums and service revenues, effective inorganic growth initiatives and solid fundamentals.
Teladoc (TDOC) to Raise Debt for Best Doctors Acquisition
by Zacks Equity Research
Teladoc, Inc. (TDOC) announced recently that it would offer senior notes worth $200 million, with the year of maturity fixed as 2022.
Medtronic CRT Devices Improve Therapy Delivery, Cut Costs
by Zacks Equity Research
Medtronic plc (MDT) recently announced positive data on cardiac resynchronization therapy (CRT) devices within its Cardiac and Vascular segment.
Hologic (HOLX) Gets FDA Clearance for Aptima HSV 1 & 2 Test
by Zacks Equity Research
Hologic, Inc. (HOLX) recently received FDA approval for the commercial launch of the Aptima Herpes Simplex Virus (HSV) 1 & 2 molecular assay on the fully automated Panther system.
Genomic Health Cancer Tests Strong, Operating Expenses a Woe
by Zacks Equity Research
On Jun 19, we issued an updated research report on Redwood City, CA-based Genomic Health Inc (GHDX), a global cancer research company with a focus on advanced molecular diagnostics.
Walgreens-Greater Than AIDS Unite to Serve Against HIV/AIDS
by Zacks Equity Research
Walgreens Boots Alliance, Inc. (WBA) recently teamed up with Greater Than AIDS, a national public information response, focused on the U.S. domestic HIV/AIDS epidemic.
Teladoc (TDOC) to Buy Best Doctors, Stock Hits New High
by Zacks Equity Research
Teladoc Inc. (TDOC) has inked a definitive agreement to acquire Best Doctors, a leader in medical consultation.
Align Technology (ALGN) Enters the S&P 500 Index, Stock Up
by Zacks Equity Research
Align Technology, Inc. (ALGN), the California-based dental major has joined the coveted S&P 500 benchmark, after the market closed on Jun 16.
Luminex (LMNX) Scores a Strong Buy Right Now: Here's How
by Zacks Equity Research
With solid growth prospects, Luminex Corporation (LMNX) carries a Zacks Rank #1 (Strong Buy) which is an attractive pick at present.
ResMed (RMD) at 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Share price of ResMed Inc. (RMD) scaled a new 52-week high of $79.22 on Jun 19, eventually closing a bit lower at $78.91.
PAREXEL to Launch Connected Journey Data-Driven Services
by Zacks Equity Research
PAREXEL International Corporation (PRXL) recently announced the launch of its proprietary data-driven services, Connected Journey.
Medtronic Posts Positive Result on Reactive ATP, Grows in AF
by Zacks Equity Research
Medtronic's (MDT) Reactive ATP therapy slows the progression of AF in patients who are being implanted with cardiac devices.
Zacks.com featured highlights: Gray Television, H&R Block, Align Technology, Raymond James Financial and KLA-Tencor
by Zacks Equity Research
Zacks.com featured highlights: Gray Television, H&R Block, Align Technology, Raymond James Financial and KLA-Tencor
Universal Health Grows on Acquisitions, Rising Debt a Drag
by Zacks Equity Research
Universal Health Services, Inc.'s (UHS)s inorganic strategies substantially make it well positioned for long-term growth.
Inogen (INGN) Scores a Strong Buy Right Now: Here's How
by Zacks Equity Research
Goleta, CA-based Inogen Inc. (INGN), a provider of portable oxygen concentrators (POC), is on a healthy growth trajectory of late.
Hologic Receives Extended FDA Clearance for SculpSure in US
by Zacks Equity Research
Hologic, Inc. (HOLX) declared that the company's subsidiary Cynosure has received FDA's expanded clearance for SculpSure.
Why Does Intuitive Surgical Score as a Strong Buy Right Now
by Zacks Equity Research
Over the last three months, Intuitive Surgical Inc. (ISRG) was trading consistently ahead of the S&P 500 Index.
5 Momentum Stocks to Scoop Up Gains Using Driehaus Strategy
by Zacks Equity Research
Risk-taking investors may use Driehaus Strategy to get strong returns by investing in momentum stocks.
DaVita (DVA) Rolls Out Alliance Site Network for CKD Trial
by Zacks Equity Research
DaVita Inc (DVA), through its subsidiary DaVita Clinical Research (DCR), recently announced the expansion of its research services to include Alliance Site Network.
Here's Why Phibro Animal Health Is Worth Buying Right Now
by Zacks Equity Research
Phibro Animal Health Corporation (PAHC), has rallied 24.2% over the past three months, ahead of the S&P 500's mere 2.6% gain.
LabCorp to Grow in Precision Med with Cancer Diagnostics Lab
by Zacks Equity Research
LabCorp's (LH) Covance drug development business has recently opened a companion diagnostics laboratory in Morrisville, North Carolina to expand capabilities in precision medicine field.
Abbott Laboratories Up on EPD & Buyouts, Pediatric Weak
by Zacks Equity Research
On Jun 14, we issued an updated research report on Illinois-based Abbott Laboratories (ABT). It is a leading distributor of health care products and services across the globe.
Henry Schein Grows on Strategic Buyouts, Competition Rife
by Zacks Equity Research
On Jun 15, we issued an updated research report on Melville, NY-based Henry Schein, Inc. (HSIC).
Haemonetics Rides on Solid Plasma, Slows Blood Center Growth
by Zacks Equity Research
On Jun 13, we issued an updated research report on Haemonetics Corporation (HAE).